Medicare Enrolled
Dr. Hadley Deberg, FNP-C
Nurse Practitioner - Family · Charlotte, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Deberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Deberg
Dr. Hadley Deberg is a nurse practitioner - family in Charlotte, NC, with 10 years of NPI registration. Based on federal Medicare data, Dr. Deberg performed 1,056 Medicare services across 499 unique beneficiaries.
Between the years covered by Open Payments, Dr. Deberg received a total of $12,484 from 83 pharmaceutical and/or device companies across 539 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Deberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years in practice
▲ Top 12% volume in NC
$12,484 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,056
Medicare services
Top 12% in NC for nurse practitioner - family
499
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
268 | $74 | $220 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
213 | $8 | $20 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
192 | $0 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
182 | $7 | $13 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
50 | $8 | $38 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
39 | $10 | $40 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $52 | $145 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
33 | $83 | $268 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
23 | $37 | $138 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
21 | $1 | $5 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.3% high complexity
28.6% medium
66.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,484
Total received (2021-2024)
Avg $3,121/year across 4 years
Top 1% in NC for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
539
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,844 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$640 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,270
2023
$3,763
2022
$3,461
2021
$1,990
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$357
PFIZER INC.
$165
Exelixis Inc.
$157
Novartis Pharmaceuticals Corporation
$155
Eisai Inc.
$141
AstraZeneca Pharmaceuticals LP
$138
Lilly USA, LLC
$136
Daiichi Sankyo Inc.
$133
Takeda Pharmaceuticals U.S.A., Inc.
$114
ABBVIE INC.
$111
Bayer Healthcare Pharmaceuticals Inc.
$109
Stemline Therapeutics Inc.
$108
GlaxoSmithKline, LLC.
$99
Genentech USA, Inc.
$96
SOBI, INC
$94
E.R. Squibb & Sons, L.L.C.
$91
Celgene Corporation
$91
Astellas Pharma US Inc
$85
ARRAY BIOPHARMA INC
$77
Deciphera Pharmaceuticals Inc.
$76
Incyte Corporation
$72
ADC Therapeutics America, Inc.
$71
Alexion Pharmaceuticals, Inc.
$52
Pharmacosmos Therapeutics Inc.
$45
Gilead Sciences, Inc.
$43
SERVIER PHARMACEUTICALS LLC
$42
Karyopharm Therapeutics Inc.
$40
Rigel Pharmaceuticals, Inc.
$40
Janssen Biotech, Inc.
$38
Aveo Pharmaceuticals, Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
GENZYME CORPORATION
$29
Alnylam Pharmaceuticals Inc.
$24
SpringWorks Therapeutics, Inc.
$24
JAZZ PHARMACEUTICALS INC.
$21
Mirati Therapeutics, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$19
TAIHO ONCOLOGY, INC.
$17
SHIELD THERAPEUTICS INC
$17
Genmab U.S., Inc.
$16
Bard Peripheral Vascular, Inc.
$14
MorphoSys, US Inc.
$14
Coherus Biosciences Inc.
$14
Top 3 companies account for 20.8% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$816
AstraZeneca Pharmaceuticals LP
$758
Merck Sharp & Dohme LLC
$600
PFIZER INC.
$521
E.R. Squibb & Sons, L.L.C.
$477
Incyte Corporation
$448
Amgen Inc.
$414
Astellas Pharma US Inc
$384
PUMA BIOTECHNOLOGY, INC.
$380
Janssen Biotech, Inc.
$334
Eisai Inc.
$306
GENZYME CORPORATION
$292
Takeda Pharmaceuticals U.S.A., Inc.
$290
Exelixis Inc.
$289
Lilly USA, LLC
$284
Genentech USA, Inc.
$270
GlaxoSmithKline, LLC.
$253
Celgene Corporation
$253
Daiichi Sankyo Inc.
$253
Karyopharm Therapeutics Inc.
$244
Seagen Inc.
$206
ABBVIE INC.
$203
Bayer Healthcare Pharmaceuticals Inc.
$184
Novocure Inc.
$166
ADC Therapeutics America, Inc.
$166
AVEO Pharmaceuticals, Inc.
$162
ARRAY BIOPHARMA INC
$157
EISAI INC.
$148
Gilead Sciences, Inc.
$142
Stemline Therapeutics Inc.
$130
Deciphera Pharmaceuticals Inc.
$123
SERVIER PHARMACEUTICALS LLC
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$117
Pharmacosmos Therapeutics Inc.
$114
Alnylam Pharmaceuticals Inc.
$112
Puma Biotechnology, Inc.
$110
Global Blood Therapeutics, Inc.
$108
Mirati Therapeutics, Inc.
$104
Regeneron Healthcare Solutions, Inc.
$104
Pharmacyclics LLC, An AbbVie Company
$103
SOBI, INC
$94
Coherus Biosciences Inc.
$89
JAZZ PHARMACEUTICALS INC.
$88
SANOFI-AVENTIS U.S. LLC
$87
AbbVie Inc.
$86
MorphoSys, US Inc.
$70
Alexion Pharmaceuticals, Inc.
$68
Epizyme, Inc.,
$66
Merck Sharp & Dohme Corporation
$62
Bayer HealthCare Pharmaceuticals Inc.
$62
Sobi, Inc
$54
Taiho Oncology, Inc.
$54
Rigel Pharmaceuticals, Inc.
$53
BeiGene USA, Inc.
$52
EMD Serono, Inc.
$51
Aveo Pharmaceuticals, Inc.
$50
PharmaEssentia USA Corporation
$49
Janssen Scientific Affairs, LLC
$46
Ipsen Biopharmaceuticals, Inc
$46
Servier Pharmaceuticals LLC
$43
Agios Pharmaceuticals, Inc.
$43
Blueprint Medicines Corporation
$41
Pharmacyclics LLC, an AbbVie Company
$41
CTI BioPharma Corp.
$40
Organon LLC
$38
ImmunoGen, Inc.
$28
RECORDATI_RARE_DISEASES_INC.
$26
SpringWorks Therapeutics, Inc.
$24
Progenics Pharmaceuticals, Inc.
$24
EUSA Pharma (US) LLC
$23
TG Therapeutics, Inc.
$23
TG THERAPEUTICS, INC.
$22
Adaptive Biotechnologies Corporation
$22
Acrotech Biopharma Inc.
$21
Acceleron Pharma, Inc.
$21
Acrotech Biopharma LLC
$18
TAIHO ONCOLOGY, INC.
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$17
SHIELD THERAPEUTICS INC
$17
Genentech, Inc.
$16
Genmab U.S., Inc.
$16
Spectrum Pharmaceuticals Inc.
$15
Bard Peripheral Vascular, Inc.
$14
Top 3 companies account for 17.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · ALUNBRIG · AUGTYRO · AYVAKIT · Alecensa · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ENHERTU · EPKINLY · ERLEADA · Elahere · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · Monoferric · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYLARIFY · PYRUKYND · Padcev · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SYLVANT · SYNAGIS · Sylvant · TABRECTA · TAZVERIK · TECENTRIQ · TIBSOVO · TUKYSA · Tibsovo · Tivdak · Trek · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Venclexta · Vonjo · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in NC.
Geographic Context
Family nurse practitioners within 10 mi
1,037
Per 100K population
91.7
County median income
$83,765
Nearest hospital
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Deberg is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NC), with low-engagement industry engagement in the top 1% of NC peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Deberg experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Deberg performed 268 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deberg receive payments from pharmaceutical companies?
Yes. Dr. Deberg received a total of $12,484 from 83 companies across 539 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deberg's costs compare to other family nurse practitioners in Charlotte?
Dr. Deberg's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Charlotte
Browse family nurse practitioners in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in NC
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in NC
Which NC family nurse practitioners receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology